Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Carboplatin|DRUG: Paclitaxel
Sponsor: Oslo University Hospital